COVID-19
As the SARS-CoV-2 virus continues to evolve, having the right research tools is critical for understanding transmission, mutations, and immunity. At HHC, we have a collection of viral samples, reagents, and controls aimed to provide scientists, laboratories, and test manufacturers with the high-quality materials needed to support essential research and test validation.
We offer an array of SARS-CoV-2 positive and negative controls, isolates, viral lysates, and cultured samples. These include heat-inactivated SARS-CoV-2 culture fluid, COVID-19 positive and negative serum panels, and more. Whether you need clinical samples to evaluate diagnostic assays, viral isolates to study evolutionary trends, or other prepared reagents, we have the reliable materials.
Alongside SARS-CoV-2, preparing for future coronavirus threats means studying endemic betacoronaviruses like OC43 and 229E. Our expanding inventory includes related viral samples as well as reagents for influenza and many other viruses.
As with any infection, having access to the right lab materials is imperative. Over the past three years, scientists and test makers have relied on our COVID-19 supplies to accelerate their work. Purchase with confidence, knowing our products undergo the most rigorous quality testing and documentation. We are committed to supporting the global public health response by equipping laboratories with the tools needed to combat SARS-CoV-2.
| Virus | Characterization | Product Number | Product Description | BSL Level | Additional Information |
| SARS-CoV-2 | Influenza A: A/Brisbane/10/07 ,Influenza B: B/Florida/02/06 , RSVB: CH93(18)-18 , SARS-COV-2: USA-WA1/2020 | NATFRC-6C | NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) | Non-Infectious, Intact Viral Particle Quality Control. | |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| NATRVP2.1-BIO Plus | NATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) ( 24x 0.6 ml + 1x 0.6 ml) |
||||
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) | Non-Infectious, Intact Viral Particle Quality Control. | |||
| Alpha (B.1.1.7); Beta (B.1.351); Delta (B.1.617.2); Gamma P.1) | NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) | Non-Infectious, Intact Viral Particle Quality Control. | ||
| USA-WA1/2020 | NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) | Non-Infectious, Intact Viral Particle Quality Control. | ||
| NATSARS(COV2)-ERC1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control ( 6x 1.0 ml) |
||||
| A-549 | NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) | Non-Infectious, Human A549 Cells, Quality Control. | ||
| NATSARS(COV2)-NEG1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml) | ||||
| USA-WA1/2020 | NATSARS(COV2)-ST | SARS-Related Coronavirus 2 (SARS-CoV-2) Stock | Non-Infectious, Intact Viral Particles Quality Control. | ||
| B.1.351 | NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| B.1.1.7 | NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| 0810229-0.5mg | Coronavirus 229E Lysate (0.5 mg) | ||||
| USA-WA1/2020 | 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| USA-WA1/2020 | 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| USA-WA1/2020 | 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| USA-WA1/2020 | 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| USA-WA1/2020 | 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| Italy-INMI1 | 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| Italy-INMI1 | 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| Hong Kong/VM20001061/2020 | 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| Hong Kong/VM20001061/2020 | 0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-21033899-01/2021 Gamma Variant |
0810617UV | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV)) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-21006055-01/2021 Zeta Variant |
0810618UV | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-21025952-01/2021 B.1.526_2021 Iota |
0810619UV | SARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-21025952-01/2021 B.1.526_2021 Iota |
0810620UV | SARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-103677-01/2020 B.1_2020 |
0810621UV | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| NY-Wadsworth-33126-01/2020 B.1.595_2020 |
0810622UV | SARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.1.7 | 0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.1.7 | 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.351 | 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.351 | 0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.1.7 | 0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.1.7 | 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| P1 | 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| P1 | 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| 0810617CFHI | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml) | ||||
| 0810618CFHI | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml) | BSL2/BSL3 | |||
| 0810619CFHI | SARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) | BSL2/BSL3 | |||
| 0810620CFHI | SARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) | BSL2/BSL3 | |||
| 0810621CFHI | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml) | BSL2/BSL3 | |||
| 0810622CFHI | SARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml) | BSL2/BSL3 | |||
| B.1.617.1 Kappa | 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.1 Kappa | 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| B.1.617.2 Delta | 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) | BSL2 | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | |
| B.1.617.2 Delta | 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | ||
| SARS-CoV-2 Recombinant | 0801043 | Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml) | |||
| 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 N gene. | ||
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x 1.0mL) | BSL2 | Inactivated, Intact Bacterial Cells containing synthetic SARS-CoV-2 sequence. Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-CoV-2 E gene and portions of the ORF1ab gene region. | ||
| SARS | 2003-00592 | NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| Coronavirus | 229E | NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| 229E | 0810229CFHI | Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) | BSL2 | Heat Inactivated Viral Culture Fluid. | |
| 229E | 0810229 | Coronavirus Strain: 229E Lysate | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| 229E | 0810229UV | Coronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL) | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | ||
| NL63 | NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| NL63 | 0810228CFHI | Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 | Heat Inactivated Viral Culture Fluid. | |
| NL63 | 0810228 | Coronavirus Strain: NL63 Lysate | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| NL63 | 0810228UV | Coronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL) | UV Inactivated Viral Culture Fluid designed for Antigen based Analytical Testing. | ||
| OC43 | NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | ||
| OC43 | 0810024CFHI | Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
BSL2 | Heat Inactivated Viral Culture Fluid. | |
| OC43 | 0810024 | Coronavirus Strain: OC43 Lysate | BSL2 | Purified, Disrupted and Heat Inactivated. | |
| MERS-CoV | Florida/USA-2_Saudi Arabia_2014 | NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) | Non-Infectious, Intact Viral Particles Quality Control. | |
| NATMR-BIO | NATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml) | ||||
| NATCOV(MR)-BIO | NATtrol MERS-S. Cerevisiae (0.6 ml) | ||||
| 0810575 | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate (1 mg) | ||||
| 0810575-0.5mg | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate (0.5 mg) | ||||
| COVID-19 samples | CV033122 | COVID-19 Cross Over Panel (40x 1.0 ml) |
No products were found matching your selection.